There are 120,000 Australians with type 1 diabetes. Currently around 15% have access to insulin pump therapy. Australia is lagging behind the US which has about twice the level of access to insulin pump therapy for people with type 1 diabetes.

The latest Australian data suggests around one in five adults with type 1 diabetes may experience hypoglycaemia unawareness and be more at risk of dangerous low blood glucose levels. Insulin pumps, continuous glucose monitoring and newer closed loop systems can potentially help prevent hypoglycaemia.

What is an insulin pump?

An insulin pump is a small battery-operated electronic device about the size of a mobile phone and is worn 24 hours a day. The rapid acting insulin is delivered via an infusion set which is inserted under the skin, delivering insulin continuously.

How much does it cost?

The average cost of the pump is $6,000-$8,000. The consumables are also expensive but are subsidised under the NDSS.

Benefits

• Research has shown that insulin pump therapy can reduce the frequency of severe hypoglycaemia as well as improve the quality of life of pump users
• Using a pump may improve blood glucose control
• Insulin pump therapy together with continuous glucose monitoring, can be potentially life-saving for people with type 1 diabetes

The insulin pump is not suitable for everyone. If you’re considering using one, you must discuss it first with your doctor or Credentialled Diabetes Educator.